PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy

Learn how experts around the world use PARP inhibitors to optimally manage patients with pancreatic cancer and BRCA1/2 or other alterations causing homologous repair deficiency with focused commentaries a podcast series an expert video roundtable and downloadable slideset.

Share

Program Content

Activities

Pancreatic Cancer: POLO
Making Sense of the Most Recent Data From the POLO Trial in Pancreatic Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 05, 2021

Expires: October 04, 2022

Pancreatic PARP Inhibitors
How I See the Role of PARP Inhibitors Changing in Pancreatic Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2022

Expires: January 30, 2023

Activities

PARPis in Pancreatic Cancer
PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2021

Expires: October 25, 2022

<i>PodcastPearls:</i> PARPis in Pancreatic Cancer
PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance Of Testing For Biomarkers Along With Current Treatment Landscape: Podcast Pearls
PDF
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2021

Expires: November 02, 2022

New Directions With PARPis
New Directions With PARP Inhibitors in Pancreatic Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 21, 2022

Expires: February 20, 2023

<i>PodcastPearls:</i> New Directions With PARPis
New Directions with PARP Inhibitors in Pancreatic Cancer: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2022

Expires: May 02, 2023

Activities

PARPi in Pancreatic Cancer
PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy
Congratulations: You achieved a completion on 04/09/2022
Slideset: PARPi in Pancreatic Cancer
PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2021

Expires: December 13, 2022

Faculty

cover img faculity

Dirk Arnold, MD, PhD

Director
Asklepios Tumorzentrum Hamburg
Department of Oncology
AK Altona
Hamburg, Germany

cover img faculity

Elena Gabriela Chiorean, MD

Professor of Medicine
Division of Medical Oncology
Department of Medicine
University of Washington
Member
Fred Hutchinson Cancer Research
Seattle, Washington

cover img faculity

Michel Ducreux, MD, PhD

Full Professor of Cancerology
Faculty of Medicine
University of Paris-Saclay
Department of Medicine
Gustave Roussy
Villejuif, France

cover img faculity

Gabriela Hobbs, MD

Assistant Professor
Clinical Director
, Leukemia
Division of Leukemia
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Eileen O Reilly, MD

Associate Professor
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Philip Agop Philip, MD, PhD, FRCP

Professor
School of Medicine
Wayne State University
Leader, Gastrointestinal Multidisciplinary Team
Department of Oncology
Karmanos Cancer Institute
Detroit, Michigan

cover img faculity

Naureen Starling, BSc(Hons), MBBS, MD(Res), FRCP

Associate Director of Clinical Research
Reader
Department of GI Cancers
The Royal Marsden Hospital/ICR
Consultant Medical Oncologist, GI Cancers
London, United Kingdom

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca